Lily Yang

15.5k total citations · 2 hit papers
179 papers, 11.1k citations indexed

About

Lily Yang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Lily Yang has authored 179 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 50 papers in Biomedical Engineering and 37 papers in Biomaterials. Recurrent topics in Lily Yang's work include Nanoparticle-Based Drug Delivery (37 papers), Nanoplatforms for cancer theranostics (35 papers) and Photoacoustic and Ultrasonic Imaging (17 papers). Lily Yang is often cited by papers focused on Nanoparticle-Based Drug Delivery (37 papers), Nanoplatforms for cancer theranostics (35 papers) and Photoacoustic and Ultrasonic Imaging (17 papers). Lily Yang collaborates with scholars based in United States, New Zealand and China. Lily Yang's co-authors include Shuming Nie, Hui Mao, Xianghong Peng, Xiaohu Gao, Zehong Cao, Dominic O. Ansari, May D. Wang, Dong M. Shin, Qiqin Yin-Goen and Andrew N. Young and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lily Yang

175 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

2007 1.8k citations Lily Yang et al. profile →
In vivo molecular and cellular imaging with quantum dots

2004 944 citations Lily Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lily Yang United States	52	4.6k	4.2k	2.9k	2.4k	1.6k	179	11.1k
Wei He China	49	2.4k 0.5×	4.5k 1.1×	2.3k 0.8×	2.4k 1.0×	802 0.5×	248	11.3k
Sangyong Jon South Korea	62	6.7k 1.5×	7.2k 1.7×	5.6k 1.9×	3.2k 1.3×	1.2k 0.7×	219	16.4k
Xiaoyang Xu China	49	4.2k 0.9×	3.9k 0.9×	3.5k 1.2×	2.4k 1.0×	869 0.5×	133	10.7k
Xinguo Jiang China	67	4.5k 1.0×	5.8k 1.4×	6.0k 2.1×	1.8k 0.8×	688 0.4×	168	13.5k
Xuemei Wang China	54	3.0k 0.7×	4.0k 1.0×	1.3k 0.4×	5.0k 2.1×	1.2k 0.7×	523	12.5k
Wei Qian China	51	5.0k 1.1×	2.8k 0.7×	1.9k 0.6×	4.0k 1.7×	4.1k 2.5×	259	13.5k
Jianghong Rao United States	64	7.8k 1.7×	6.5k 1.5×	2.6k 0.9×	4.8k 2.0×	553 0.3×	159	15.0k
Pan Li China	59	4.8k 1.1×	4.3k 1.0×	1.8k 0.6×	3.1k 1.3×	360 0.2×	432	13.7k
Zhuo Chen China	64	4.2k 0.9×	4.6k 1.1×	1.3k 0.4×	4.5k 1.9×	699 0.4×	432	14.7k
Samuel Achilefu United States	65	6.4k 1.4×	4.0k 0.9×	1.7k 0.6×	4.3k 1.8×	914 0.6×	337	14.8k

Countries citing papers authored by Lily Yang

Since Specialization

Citations

This map shows the geographic impact of Lily Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Yang more than expected).

Fields of papers citing papers by Lily Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Yang. The network helps show where Lily Yang may publish in the future.

Co-authorship network of co-authors of Lily Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Yang. A scholar is included among the top collaborators of Lily Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Yang. Lily Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yang, Lily, et al.. (2024). Effectiveness of a web-enabled psychoeducational resource for postpartum depression and anxiety among women in British Columbia. Archives of Women s Mental Health. 27(6). 995–1010. 3 indexed citations

2.

Liu, William, Subir Goyal, Tongrui Liu, et al.. (2024). Antagonizing vasoactive intestinal peptide (VIP) receptors with Muc16CD-directed armored CAR T cells for pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). 2558–2558. 1 indexed citations

3.

Liu, Tongrui, et al.. (2024). Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer. PubMed. 32(4). 200868–200868. 1 indexed citations

4.

Yang, Lily, Marie‐Claude Boily, Minttu M. Rönn, et al.. (2023). Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020). PLoS Medicine. 20(1). e1004143–e1004143. 34 indexed citations

5.

Yang, Lily, et al.. (2023). From Ports2Arms: reimagining demand creation for the African context. SHILAP Revista de lepidopterología. 3. 1257990–1257990.

6.

Strudwick, Gillian, Lianne Jeffs, Jessica Kemp, et al.. (2022). Identifying and adapting interventions to reduce documentation burden and improve nurses’ efficiency in using electronic health record systems (The IDEA Study): protocol for a mixed methods study. BMC Nursing. 21(1). 213–213. 6 indexed citations

7.

Leo, Angela, Erica Pranzini, Laura Pietrovito, et al.. (2021). Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells. Cancers. 13(14). 3551–3551. 2 indexed citations

8.

Yang, Hao, Dingkang Wang, Xianjin Dai, et al.. (2019). Miniature fluorescence molecular tomography (FMT) endoscope based on a MEMS scanning mirror and an optical fiberscope. Physics in Medicine and Biology. 64(12). 125015–125015. 5 indexed citations

9.

Gao, Ning, Erica N. Bozeman, Weiping Qian, et al.. (2017). Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery. Theranostics. 7(6). 1689–1704. 67 indexed citations

10.

Zheng, Zhousan, Nan Shao, Hui-Wen Weng, et al.. (2014). Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma. Medical Oncology. 32(1). 275–275. 32 indexed citations

11.

Yang, Lily. (2013). In Vivo Imaging Technology of Small Animals Applied in Cancer Study. Journal of Ningbo University. 1 indexed citations

12.

Yang, Lily. (2013). Hexaminolevulinate Blue Light Cystoscopy: A Review of Its Use in the Diagnosis of Bladder Cancer. Molecular Diagnosis & Therapy. 18(1). 105–116. 9 indexed citations

13.

Yang, Lily & Kate McKeage. (2012). Axitinib. Drugs. 72(18). 2375–2384. 13 indexed citations

14.

Liu, Tongrui, Rami Yacoub, LaTonia Taliaferro‐Smith, et al.. (2011). Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells. Molecular Cancer Therapeutics. 10(8). 1460–1469. 88 indexed citations

15.

Yang, Lily & Paul L. McCormack. (2011). MMX® Mesalazine. Drugs. 71(2). 221–235. 17 indexed citations

16.

Yang, Lily. (2011). Oral Paliperidone. CNS Drugs. 25(6). 523–538. 11 indexed citations

17.

Yang, Lily & Lesley J. Scott. (2010). Escitalopram in the Treatment of Major Depressive Disorder in Adolescent Patients†. CNS Drugs. 24(7). 621–623.

18.

Yang, Lily & Lesley J. Scott. (2009). Palonosetron. Drugs. 69(16). 2257–2278. 54 indexed citations

19.

Yang, Lily & Caroline M. Perry. (2009). Zonisamide. CNS Drugs. 23(8). 703–711. 13 indexed citations

20.

Yang, Lily & Greg L. Plosker. (2008). Desvenlafaxine Extended Release. CNS Drugs. 22(12). 1061–1069. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact